History of myeloid-derived suppressor cells
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of immune cells from the myeloid lineage, are a major component of the immunosuppressive TME [93].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
The cited source says what the claim attributes to it.
In the citing paper
“The TME is immunosuppressive, thus rendering the immune system less effective in killing cancer cells.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Goycoolea, A. (1997) · Cited by 3,615
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Research works printed but not linked: 1
- Sonnenfeld A Leukamische reaktiones bei carcinoma Zeitschrift f Klin Med 1929 111
Cited by
Items 801–900 of 1,000
Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection
Katahira, Y., Higuchi, H., Matsushita, H., Yahata, T., Yamamoto, Y., Koike, R., Ando, K., Sato, K., Imadome, K., & Kotani, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49937-w · Cited by 14
Brajer-Luftmann, B., Nowicka, A., Kaczmarek, M., Wyrzykiewicz, M., Yasar, S. J., Piorunek, T., Sikora, J., & Batura‐Gabryel, H. (2019) · Journal of Immunology Research · doi:10.1155/2019/9708769 · Cited by 13
The Good and the Bad: Immune Cells and Hypertension
Hay, M. (2015) · Circulation Research · doi:10.1161/circresaha.115.307506 · Cited by 13
Ma, W., Luo, H., Lv, J., Wen, P., Liu, G., Yu, Z., Yáng, Z., & Huang, W. (2024) · Advanced Materials · doi:10.1002/adma.202402929 · Cited by 12
Nian, S., Wang, K., Wang, J., Wang, S., Li, C., Li, N., & Chen, J. (2025) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2025.01.030 · Cited by 12
Myeloma bone disease: Progress in pathogenesis
Xi, H., An, R., Lu, L., Wang, G., Yi, T., & Gao, L. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.08.003 · Cited by 12
Szentkereszty, M., Komlósi, Z. I., Szűcs, G., Barna, G., Tamási, L., Losonczy, G., & Gálffy, G. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00661-w · Cited by 12
Li, X., Li, J., Jiang, N., Chen, J., Liang, Z., Zhao, Z., & Xing, Y. (2020) · Aging · doi:10.18632/aging.202149 · Cited by 12
Myeloid derived suppressor cells and the release of micro-metastases from dormancy
Khadge, S., Cole, K., & Talmadge, J. E. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10098-8 · Cited by 13
Self-citationMartins, N. S., Fraga‐Silva, T. F. D. C., Corrêa, G. F., Boko, M. M. M., Ramalho, L. N. Z., Rodrigues, D. M., Hori, J. I., Costa, D. L., Bastos, J. K., & Bonato, V. L. D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111763 · Cited by 13
The Effects of Tamoxifen on Tolerogenic Cells in Cancer
Idris, R. A. M., Mussa, A., Ahmad, S., Al-Hatamleh, M. A. I., Hassan, R., Din, T. A. D. A. T., Rahman, W. F. W. A., Lazim, N. M., Boer, J. C., Plebanski, M., et al. (2022) · Biology · doi:10.3390/biology11081225 · Cited by 13
Scheer, I., Becker, I., Schmitter, C., Semrau, S., Fietkau, R., Gaipl, U. S., Frey, B., & Donaubauer, A.-J. (2023) · Cells · doi:10.3390/cells12040516 · Cited by 12
Dual roles of myeloid-derived suppressor cells in various diseases: a review
Nepal, M. R., Shah, S., & Kang, K. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01504-2 · Cited by 12
Kapanadze, T. G., Medina‐Echeverz, J., Gamrekelashvili, J., Weiss, J. M., Wiltrout, R. H., Kapoor, V., Hawk, N. V., Terabe, M., Berzofsky, J. A., Manns, M. P., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201445093 · Cited by 13
Chronic hepatitis B surface antigen seroclearance‐related immune factors
Yuan, T., Jiang, Y., Li, M., & Li, W. (2016) · Hepatology Research · doi:10.1111/hepr.12726 · Cited by 12
EFIS lecture. Immune response to tuberculosis: How to control the most successful pathogen on earth
Kaufmann, S. H. E. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.05.006 · Cited by 15
Sahoo, M., Katara, G. K., Bilal, M. Y., Ibrahim, S. A.-S., Kulshrestha, A., Fleetwood, S., Suzue, K., & Beaman, K. D. (2018) · Oncotarget · doi:10.18632/oncotarget.26061 · Cited by 12
Qian, F., & Han, B. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001124 · Cited by 13
RCC Immune Microenvironment Subsequent to Targeted Therapy: A Friend or a Foe?
Chen, W., Pan, X., & Cui, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.573690 · Cited by 14
Myeloid-derived suppressor cells in gastroenteropancreatic neuroendocrine neoplasms
Liu, M., Zhang, Y., Chen, L., Lin, Y., He, Q., Zeng, Y., Chen, M., & Chen, J. (2020) · Endocrine · doi:10.1007/s12020-020-02467-2 · Cited by 12
Centonze, G., Lagano, V., Sabella, G., Mangogna, A., Garzone, G., Filugelli, M., Belmonte, B., Cattaneo, L., Crisafulli, V., Pellegrinelli, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081741 · Cited by 12
Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2)
Soler, D. C., Kerstetter-Fogle, A. E., Young, A. B., Rayman, P. A., Finke, J. H., Debanne, S. M., Cooper, K. D., Barnholtz‐Sloan, J. S., Sloan, A. E., & McCormick, T. S. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.12.011 · Cited by 12
Xie, J. (2014) · OncoImmunology · doi:10.4161/onci.29180 · Cited by 12
Lian, J., Lin, D., Huang, Y., Chen, X., Chen, L., Zhang, F., Tang, P., Xie, J., Hou, X., Du, Z., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00834-5 · Cited by 12
Li, C., Xue, Y., Yinwang, E., & Ye, Z. (2025) · Cancer Reports · doi:10.1002/cnr2.70044 · Cited by 13
Benign non-immune cells in tumor microenvironment
Liu, S., Liu, C., He, Y., & Li, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561577 · Cited by 11
Contributions of neutrophils to the adaptive immune response in autoimmune disease
Pietrosimone, K. M., & Liu, P. (2015) · World Journal of Translational Medicine · doi:10.5528/wjtm.v4.i3.60 · Cited by 11
Liu, X., Yu, J., Song, G., Di, L.-J., Jiang, H., Yan, Y., Xu, L., Zhang, R., Ran, R., Wang, J., et al. (2020) · The Breast · doi:10.1016/j.breast.2020.11.006 · Cited by 11
Immuno-onco-metabolism and Therapeutic Resistance
Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11
Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter
Wang, G., Liu, Y., Liu, S., Lin, Y., & Hu, C. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012647 · Cited by 12
Aintablian, A., Strozniak, S., Heuer, M., & Lutz, M. B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130600 · Cited by 11
The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model
Jiang, Q., Duan, J., Kaer, L. V., & Yang, G. (2023) · Aging and Disease · doi:10.14336/ad.2023.0323-1 · Cited by 13
Unraveling the Complexities of Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
Zhu, Y., & Cao, S. “. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073291 · Cited by 11
Zhang, Z., Bulur, P. A., Doǧan, A., Gastineau, D. A., Dietz, A. B., & Lin, Y. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.996470 · Cited by 11
[Tumor microenvironment--the critical element of tumor metastasis].
Fang, Y., & Yu, Y. (2015) · PubMed Central · doi:10.3779/j.issn.1009-3419.2015.01.08 · Cited by 12
Mion, F., Vetrano, S., Tonon, S., Valeri, V., Piontini, A., Burocchi, A., Petti, L., Frossi, B., Gulino, A., Tripodo, C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1336593 · Cited by 13
Mechanisms of Gastrointestinal Malignancies
Katona, B. W., & Lynch, J. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00066-9 · Cited by 13
Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy
Kondoh, N., Mizuno‐Kamiya, M., Takayama, E., Kawati, H., Umemura, N., Yamazaki, Y., Mitsudo, K., & Tohnai, I. (2018) · The Open Dentistry Journal · doi:10.2174/1874210601812010455 · Cited by 11
Hyperpolarized 13C magnetic resonance imaging for noninvasive assessment of tissue inflammation
Anderson, S., Grist, J. T., Lewis, A., & Tyler, D. J. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4460 · Cited by 12
Wang, Y., Qian, J., Xu, W., Hou, G., Zhao, K., Wang, J., Wang, W., & Suo, A. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141815 · Cited by 11
Zhang, M., Shi, X., Zhao, J., Guo, W., & Zhou, J. (2023) · Biomedical Reports · doi:10.3892/br.2023.1637 · Cited by 12
Fědorová, L., Pilátová, K., Selingerová, I., Bencsiková, B., Budínská, E., Zwinsova, B., Brychtová, V., Langrová, M., Šefr, R., Valík, D., et al. (2018) · Klinicka onkologie · doi:10.14735/amko20182s88 · Cited by 11
Hu, F., Liu, J., Liu, H., Li, F., Wan, M., Zhang, M., Jiang, Y., & Rao, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700168 · Cited by 12
Targeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach
Mahhengam, N., Kazemnezhad, K., Budi, H. S., Ansari, M. J., Bokov, D. O., Suksatan, W., Thangavelu, L. P., & Siahmansouri, H. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2032095 · Cited by 12
Zhang, S., Wu, K., Liu, Y., Lin, Y., Zhang, X., Zhou, J., Zhang, H., Pan, T. S., & Fu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156549 · Cited by 11
Editorial: The intricacy of choice: can bacteria decide what type of myeloid cells to stimulate?
Gabrilovich, D. I. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ce0514-271r · Cited by 11
Self-citationCristi, F., Walters, M., Narayan, N., Agopsowicz, K. C., Hitt, M., & Shmulevitz, M. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100743 · Cited by 10
Lv, X., Zhang, P., Zhang, E., & Yang, S. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03765-7 · Cited by 11
Chu, Y., Shen, H., Li, Q., Shen, B., Zhang, Y., Wang, D., Zhu, W., Wang, S., & Ma, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1565993 · Cited by 10
Zhou, D., Chen, Y., Liu, X., He, J., Shen, L., He, Y., Zhang, J., Zhou, Y., Zhang, N., Xu, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70411 · Cited by 10
Molecular mechanisms governing the differentiation and expansion of myeloid-derived suppressor cells
Wang, K., Wang, X., & Sun, N. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1677201 · Cited by 10
GLP-1 signaling in tumor metabolism and immunity: mechanisms and strategies
Luo, Y., Xu, H., Zhao, Y., Yang, B., & Zhang, Y. (2025) · Food & Function · doi:10.1039/d5fo03273c · Cited by 10
SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice
Hamilton, M. J., Halvorsen, E. C., LePard, N. E., Bosiljcic, M., Ho, V. W., Lam, V., Banáth, J. P., Bennewith, K. L., & Krystal, G. (2015) · Oncotarget · doi:10.18632/oncotarget.6611 · Cited by 11
Cancer stem cell‐immune cell collusion in immunotherapy
Wang, Y. Y., Wang, W., & Sun, Z. (2023) · International Journal of Cancer · doi:10.1002/ijc.34421 · Cited by 11
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
Andrés, C., de la Lastra, J. M. P., Juan, C., Plou, F. J., & Pérez‐Lebeña, E. (2023) · Vaccines · doi:10.3390/vaccines11020218 · Cited by 10
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
Sharma, S., Rana, R., Prakash, P., & Ganguly, N. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04715-1 · Cited by 10
Mahanti, K., Saha, J., Sarkar, D., Pramanik, A., Chattopadhyay, N. R., & Bhattacharyya, S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae013 · Cited by 10
Role of cancer stem cell ecosystem on breast cancer metastasis and related mouse models
Peng, X., 复旦大学附属肿瘤医院 & 生物医学研究院; 复旦大学遗传工程国家重点实验室; 复旦大学肿瘤研究所; 复旦大学附属肿瘤医院肿瘤科; 上海市乳腺肿瘤重点实验室; 上海市医学表观遗传学重点实验室; 上海市放射肿瘤学重点实验室; 科技部医学表观遗传与分子代谢国际合作基地; 复旦大学上海医学院, 上. 2., Dong, H., Zhang, L., & Liu, S. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.411 · Cited by 10
Feng, C., Liang, X., Fan, R., Mu, M., Zhou, L., & Guo, G. F. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.96 · Cited by 10
The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing
Abdelrady, Y. A., Thabet, H., & Sayed, A. M. M. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00662-w · Cited by 12
Wang, Y., Tan, J., Li, J., Chen, H., & Wang, W. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211039940 · Cited by 10
Yang, B., Zhou, M., Wu, Y., Ma, Y., Tan, Q., Yuan, W., & Ma, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769047 · Cited by 10
Perico, M. E., Maluta, T., Conti, G., Vella, A., Provezza, L., Cestari, T., Cao, G. D., Segalla, L., Tecchio, C., Benedetti, F. M., et al. (2021) · Cells · doi:10.3390/cells11010001 · Cited by 10
Li, Y., Li, H., He, Q., & Yang, X. (2022) · Molecules · doi:10.3390/molecules28010195 · Cited by 10
The Role of Myeloid-Derived Suppressor Cells in Immunosuppression in Brain Tumors
Gabrusiewicz, K. R., Colwell, N. A., & Heimberger, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802420-1.00004-1 · Cited by 10
A Novel CD48-Based Analysis of Sepsis-Induced Mouse Myeloid-Derived Suppressor Cell Compartments
Jia, B., Zhao, C., Li, G., Kong, Y., Ma, Y., Wang, Q., Wang, B., & Zeng, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/7521701 · Cited by 10
Liu, L., Lin, Q., Peng, J., Fang, J., Tan, Z., Tang, H., Kwan, K., Nishiura, K., Liang, J., Kwok, H., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103008 · Cited by 10
Katayama, C., Yokobori, T., Ozawa, N., Suga, K., Shiraishi, T., Okada, T., Osone, K., Katoh, R., Suto, T., Motegi, Y., et al. (2021) · Cancer Reports · doi:10.1002/cnr2.1364 · Cited by 11
Li, T., Zhang, Z., Wang, Y., Xu, D., Dong, J., Zhu, Y., & Wang, Z. (2021) · Journal of Cancer · doi:10.7150/jca.54408 · Cited by 10
Phenotypic and functional dissection of myeloid-derived suppressor cells
Han, S., & Yang, Y. D. (2016) · Applied Biological Chemistry · doi:10.1007/s13765-016-0172-9 · Cited by 10
Immunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells
Cho, W. K., Shin, S.-W., Kim, S., Hong, C.-W., Choi, C., Park, W., & Noh, J. M. (2016) · Radiation Oncology Journal · doi:10.3857/roj.2016.01816 · Cited by 12
Ye, Y., Dai, L., Gu, H., Yang, L., Xu, Z., & Li, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1381002 · Cited by 9
Wang, S., Wang, T., Wu, S., Zhang, L., & Zou, X. (2025) · SIAM Journal on Applied Mathematics · doi:10.1137/23m1593061 · Cited by 12
Myeloid cells are involved in tumor immunity, metastasis and metabolism in tumor microenvironment
Zhang, C., Song, Y., Yang, H., & Wu, K. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10012-y · Cited by 9
Unraveling the functional landscape of ATRA- and DMSO-differentiated HL-60 cells
Ghonyan, S., Poghosyan, D., Martirosyan, A., Margaryan, S., Avetisyan, A., Khachatryan, Z., & Manukyan, G. P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331783 · Cited by 11
Bonometti, A., Borsani, O., Rumi, E., Ferretti, V. V., Dioli, C., Lucato, E., Paulli, M., & Boveri, E. (2022) · Cancer Medicine · doi:10.1002/cam4.5542 · Cited by 9
Cao, X., Lan, Q., Xu, H., Liu, W., Cheng, H., Hu, X., He, J., Yang, Q., Lai, W., & Chu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113500 · Cited by 9
Hsu, C., Ahmed, A. T., Rab, S. O., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Nathiya, D., Kariem, M., & KADHIM, A. J. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114424 · Cited by 11
Li, X., Chen, J., Chen, Y., Qiao, Y., Zhao, L., Jiang, N., Wu, X., & Xing, Y. (2021) · Communications Biology · doi:10.1038/s42003-021-01769-z · Cited by 9
Scheurer, J., Kitt, K., Huber, H. J., Fundel‐Clemens, K., Pflanz, S., Debatin, K., & Strauß, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754316 · Cited by 9
Taub, C. J., Diaz, A., Blomberg, B. B., Jutagir, D. R., Fisher, H. M., Gudenkauf, L. M., Lippman, M. E., Hudson, B. I., & Antoni, M. H. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001109 · Cited by 10
Lü, L., Jin, Y. C., Tong, Y., Xiao, L., Hou, Y., Liu, Z., & Dou, H. (2023) · BBA Advances · doi:10.1016/j.bbadva.2023.100103 · Cited by 9
δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8+ T cell activation
Huang, F., Chen, J., Lan, R., Wang, Z., Chen, R., Lin, J., Zhang, L., & Fu, L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1450713 · Cited by 11
Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies
Ernst, P., & Heidel, F. H. (2021) · Cancers · doi:10.3390/cancers13040612 · Cited by 9
PMA induces the differentiation of monocytes into immunosuppressive MDSCs
Wang, H., Ji, J., Zhuang, Y., Zhou, X., Zhao, Y. X., & Zhang, X. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13657 · Cited by 9
Myeloid derived suppressor cell: A new player in periodontal disease?
Valero-Monroy, O., Garcia-Cervantes, G., Marquez-Corrales, L. F., Leija-Montoya, A. G., Sandoval-Basilio, J., Martínez-Coronilla, G., Isiordia‐Espinoza, M. A., & Serafín‐Higuera, N. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.08.010 · Cited by 10
Ka, H. I., Mun, S. H., Han, S., & Yang, Y. D. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.056860 · Cited by 8
Zhou, J., Yin, H., Pan, J., Yin, R., Wei, X., Shen, M., Cai, L., Liu, Z., Zhao, J., Chen, W., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07948-8 · Cited by 12
Advances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases
Yang, Y., Liu, J., Liu, J., Wei, S., Kong, X., Mu, W., Liu, Y., & Zhang, N. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.013 · Cited by 10
Scrimini, S., Pons, J., & Sauleda, J. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.11.006 · Cited by 9
Wang, J., Li, X., Zhang, T., Wang, C., & Zhen, M. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00599b · Cited by 8
Li, H., Yang, F., Zhang, L., Zhao, R., Li, X., & Li, H. (2023) · Integrative Cancer Therapies · doi:10.1177/15347354231187000 · Cited by 8
Small extracellular vesicles: Multi-functional aspects in non-small cell lung carcinoma
Padinharayil, H., & George, A. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104341 · Cited by 8
Increased blood CSF3R+ myeloid-derived suppressor cell is a predictor for breast cancer recurrence
Li, Y.-L. (2024) · American Journal of Cancer Research · doi:10.62347/mukd2745 · Cited by 8
Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review
Pérez-Peláez, B., Jiménez‐Cortegana, C., de la Cruz‐Merino, L., & Sánchez‐Margalet, V. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090549 · Cited by 8
Zhang, L., Tan, R., Pan, T., & Qu, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1417846 · Cited by 8
Scrimini, S., Pons, J., & Sauleda, J. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2015.07.003 · Cited by 10
Immunological parameters as a new lead in the diagnosis of ovarian cancer.
Baert, T., Timmerman, D., Vergote, I. B., & Coosemans, A. (2015) · PubMed · Cited by 8
Wang, Y., Gao, Y., Zhang, C., Yue, J., Wang, R., Liu, H., Yang, X., Zhang, Y., & Yang, R. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200195 · Cited by 8
Wang, G., Zhou, M., Zhang, Y., Cai, H.-M., Chiang, S. T., Chen, Q., Han, T., & Li, R.-X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.989141 · Cited by 8
Metadata
- Authors
- Talmadge, J. E., & Gabrilovich, D. I.
- Affiliations
- University of Nebraska Medical Center (US)
- The Wistar Institute (US)
- Corresponding author
- Talmadge, James E.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 739-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4358792
- OpenAlex
- W2122403898
- Cited by
- 1,148
- References
- 197
- Citations by year
- 2026: 29 · 2025: 57 · 2024: 80 · 2023: 74 · 2022: 105 · 2021: 132 · 2020: 110 · 2019: 95 · 2018: 101 · 2017: 90 · 2016: 129 · 2015: 93 · 2014: 43 · 2013: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- myeloid-derived suppressor cells, tumor microenvironment, T cell suppression, immune evasion, tumor progression, metastasis, multipotent progenitors
- MeSH terms
- Animals, Antigens, Differentiation, Antigens, Neoplasm, Cell Differentiation, Cell Biology, Hematopoiesis, Extramedullary, Humans, Leukemoid Reaction, Medical Oncology, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Chemokines, Cell Lineage, Tumor Escape, Hematopoietic Stem Cell Mobilization, Myeloid Cells, Myeloid Progenitor Cells, Multipotent Stem Cells, Tumor Burden, History, 20th Century, History, 21st Century, Mice, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.